Immediate Impact
1 by Nobel laureates 61 standout
Citing Papers
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Daniela Cullurà being referenced
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC).
2023
Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniela Cullurà | 186 | 200 | 54 | 96 | 21 | 307 | |
| Yingsheng Wen | 143 | 152 | 72 | 105 | 27 | 314 | |
| Jingjing Wang | 98 | 176 | 50 | 79 | 28 | 317 | |
| Niels Viggo Jensen | 185 | 230 | 92 | 95 | 28 | 363 | |
| Li Bai | 139 | 193 | 36 | 41 | 25 | 304 | |
| Pauline du Rusquec | 210 | 148 | 34 | 62 | 24 | 370 | |
| Wenxiao Jia | 203 | 146 | 38 | 84 | 24 | 343 | |
| Yuzuru Watanabe | 157 | 141 | 35 | 89 | 24 | 336 | |
| Letizia Laera | 117 | 173 | 39 | 72 | 32 | 317 | |
| Gui-Ming Zhang | 140 | 151 | 74 | 117 | 21 | 352 | |
| Chukwuemeka Ikpeazu | 181 | 139 | 41 | 63 | 23 | 340 |
All Works
Loading papers...